David G

David G. Watumull, President and CEO

More than twenty years experience as a biotechnology industry executive, analyst, and investment banker. Co-founder of Cardax and co-inventor of Cardax technology. As CEO of Hawaii Biotech, led efforts that raised more than $25 million in equity financing and $30 million in grant funding. Started and led a West Nile virus vaccine program at Hawaii Biotech that achieved success in a human proof of concept study. View Biography >>

Gilbert R

Gilbert M. Rishton, Ph.D., Chief Science Officer

Former drug discovery and development leader at Amgen. Built Amgen’s Small Molecule Drug Discovery Group, managed chemistry for preclinical and clinical development of Sensipar, and led medicinal chemistry for Amgen’s Secretase Team. Founder and Director of the Channel Islands Alzheimer’s Institute. View Biography >>

Russell

John Russell, Chief Financial Officer

More than 20 years of accounting, finance, operations, and SEC reporting experience in biopharmaceutical and high-tech industries. From 2010 to the present, he has served as Chief Financial Officer for various privately-held start-up companies. Licensed CPA in Hawaii and has a B.A. in Economics/Accounting from Claremont McKenna College. View Biography >>

Timothy K

Timothy J. King, Ph.D., Vice President, Research

Over 22 years of combined academic and private sector scientific research conducting biomedical research utilizing cell culture and genetically-engineered mouse model systems. Formerly a Staff Scientist at the Fred Hutchinson Cancer Research Center. View Biography >>

David M

David M. Watumull, Vice President, Operations

Fifteen years experience in biotechnology with Hawaii Biotech and Cardax. Has day-to-day responsibility for the Company’s operations as well as relations with partners and contractors for the production and testing of Cardax compounds. Manages the Cardax intellectual property portfolio. View Biography >>